Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller
« Previous
123456789101112
Next »

The year ahead

Some predictions about what's in store for contract services in 2010.
Jan 1, 2010
By: Jim Miller

It's customary among columnists to begin a new year with some predictions about what's to come. We don't honour that custom every year, but with what the contract services industry went through in 2009, it seemed appropriate to share thoughts on what we expect for 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 2, 2009
By: Jim Miller

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Dec 2, 2009
By: Jim Miller

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Squeezed for cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Dec 1, 2009
By: Jim Miller

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

The Outlook for Contract Services: Is That Light at the End of the Tunnel?

Nov 24, 2009
By: Jim Miller

View Jim Miller's presentation from the AAPS 2009 Meeting and Exhibition.

Sizing Up the CDMO Market

A new analysis highlights growth drivers and challenges for clinical supply-chain services.
Nov 10, 2009
By: Jim Miller

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Nov 2, 2009
By: Jim Miller

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Reality not insanity

CDMOs waiting for the pipeline to come roaring back are kidding themselves.
Nov 1, 2009
By: Jim Miller

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

Expansion Plan

Contract-service providers are expanding their offerings in this slow-growth environment.
Oct 9, 2009
By: Jim Miller

Contract-service providers are expanding their offerings in this slow-growth environment.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here